RT Journal Article
SR Electronic
T1 Modelling pooling strategies for SARS-CoV-2 testing in a university setting
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.19.20248560
DO 10.1101/2021.01.19.20248560
A1 Gibran Hemani
A1 Amy C Thomas
A1 Josephine G. Walker
A1 Adam Trickey
A1 Emily Nixon
A1 David Ellis
A1 Rachel Kwiatkowska
A1 Caroline Relton
A1 Leon Danon
A1 Hannah Christensen
A1 Ellen Brooks-Pollock
YR 2021
UL http://medrxiv.org/content/early/2021/01/20/2021.01.19.20248560.abstract
AB Pre-symptomatic and asymptomatic transmission of SARS-CoV-2 are important elements in the Covid-19 pandemic, and until vaccines are made widely available there remains a reliance on testing to manage the spread of the disease, alongside non-pharmaceutical interventions such as measures to reduce close social interactions. In the UK, many universities opened for blended learning for the 2020-2021 academic year, with a mixture of face to face and online teaching. In this study we present a simulation framework to evaluate the effectiveness of different asymptomatic testing strategies within a university setting, across a range of transmission scenarios. We show that when positive cases are clustered by known social structures, such as student households, the pooling of samples by these social structures can substantially reduce the total cost of conducting RT-qPCR tests. We also note that routine recording of quantitative RT-qPCR results would facilitate future modelling studies.Competing Interest StatementJGW has received research funding from Gilead Sciences unrelated to this research. The authors declare no conflicts of interest.Funding StatementGH is funded by the Wellcome Trust [208806/Z/17/Z]. HC and EBP would like to acknowledge support from the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation at the University of Bristol. HC is additionally funded through an NIHR Career Development Fellowship [CDF-2018-11-ST2-015]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. CR is a member of the MRC Integrative Epidemiology Unit and receives support from 501 the MRC (MC_UU_00011/5) and the University of Bristol. EN and EBP are supported by the EPSRC (MR/V038613/1). ATh is supported by Wellcome (217509/Z/19/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll simulations were conducted using code from https://github.com/explodecomputer/covid-uob-pooling. https://github.com/explodecomputer/covid-uob-pooling